Phathom Pharmaceuticals (PHAT) Stock Insights
$508.06M
Market Cap
-4.48
P/E
8.76
Forward P/E
68
Score
PHAT price $6.28 +0.29 +4.84%
Stocklytics score rationale: value 60, quality 44, growth 100.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 682000 | 55252000 | 175110000 |
Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments. A pivotal asset for the company is vonoprazan, a distinctive potassium-competitive acid blocker (P-CAB) designed to effectively inhibit gastric acid production, for which Phathom holds commercial rights across the United States, Europe, and Canada…
PHAT fair value $30.53. Price $6.28. Price is 79% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 52.30M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 80.90M. Net debt 81.83M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | -0.11 | — | 84.82M |
| 2026-07-30 | -0.21 | -0.18 | 74.27M | 73.23M |
| 2026-04-30 | -0.37 | -0.27 | 58.30M | 55.90M |
| 2026-02-26 | -0.29 | -0.32 | 57.58M | 57.17M |
| 2025-10-30 | -0.41 | -0.40 | 49.50M | 46.99M |
| 2025-08-07 | -0.79 | -0.76 | 39.50M | 46.77M |
| 2025-05-01 | -1.07 | -1.06 | 28.52M | 35.65M |
| 2025-03-06 | -0.79 | -1.29 | 29.66M | 29.04M |
| 2024-11-07 | -1.32 | -1.57 | 16.35M | 25.77M |
| 2024-08-08 | -1.25 | -1.20 | 7.32M | 5.81M |
| 2024-05-09 | -1.42 | -1.43 | 1.91M | 2.05M |
| 2024-03-07 | -1.39 | -1.08 | 682.00K | 400.89K |
| 2023-11-09 | -0.76 | -0.95 | — | 800.00K |
| 2023-08-10 | -0.84 | -0.95 | — | — |
| 2023-05-10 | -0.89 | -1.34 | — | — |
| 2023-02-28 | -1.33 | -1.50 | — | 200.00K |
| 2022-11-08 | -1.32 | -1.32 | — | — |
| 2022-08-02 | -1.33 | -1.03 | — | — |
| 2022-05-10 | -1.07 | -0.97 | — | 211.00K |
| 2022-03-01 | -0.95 | -0.86 | — | — |
| 2021-11-08 | -0.98 | -0.78 | — | — |
| 2021-08-10 | -1.00 | -1.07 | — | — |
| 2021-05-11 | -0.96 | -1.11 | — | — |
| 2021-03-30 | -1.58 | -0.93 | — | — |
| 2020-11-10 | -1.02 | -0.68 | — | — |
| 2020-08-06 | -0.64 | -0.56 | — | — |
| 2020-05-12 | -0.62 | -0.59 | — | — |
| 2020-03-19 | -3.97 | -1.25 | — | — |
| 2019-11-25 | -9.30 | -1.14 | — | — |
| 2019-10-28 | -10.23 | — | — | — |
| 2019-03-31 | -0.15 | — | — | — |
| 2018-12-31 | -0.06 | — | — | — |
| 2018-09-30 | -0.03 | — | — | — |
| 2018-06-30 | -0.05 | — | — | — |
| 2018-03-31 | -0.05 | — | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Narula Sanjeev | Sell | 13.48K | $6.78 | 91.43K |
| 2026-09-03 | Breedlove Robert Charles | Sell | 460 | $9.05 | 4.16K |
| 2026-07-14 | Breedlove Robert Charles | Sell | 1.55K | $11.04 | 17.16K |
| 2026-05-22 | Parikh Asit | Buy | 28.00K | — | — |
| 2026-05-22 | Parikh Asit | Sell | 28.00K | — | — |
| 2026-05-20 | Parikh Asit | Buy | 17.50K | $4.95 | 86.62K |
| 2026-05-20 | Parikh Asit | Sell | 17.50K | $4.95 | 86.62K |
| 2026-05-19 | Parikh Asit | Buy | 24.12K | — | — |
| 2026-05-19 | Topper James N | Buy | 24.12K | — | — |
| 2026-05-19 | Stenhouse Mark | Buy | 24.12K | — | — |
| 2026-05-19 | FIELDS HEIDI | Buy | 24.12K | — | — |
| 2026-05-19 | COLA MICHAEL F | Buy | 24.12K | — | — |
| 2026-05-19 | KARBE FRANK | Buy | 24.12K | — | — |
| 2026-05-19 | Schroeder Theodore R | Buy | 24.12K | — | — |
| 2026-03-10 | Parikh Asit | Buy | 40.00K | — | — |
| 2026-03-10 | Parikh Asit | Sell | 40.00K | — | — |
| 2026-02-27 | Breedlove Robert Charles | Buy | 2.79K | — | — |
| 2026-02-27 | Breedlove Robert Charles | Sell | 964 | $12.56 | 12.11K |
| 2026-02-27 | Breedlove Robert Charles | Sell | 414 | $12.56 | 5.20K |
| 2026-02-27 | Breedlove Robert Charles | Buy | 13.00K | — | — |
| 2026-02-10 | Cook Anne Marie | Buy | 3.46K | — | — |
| 2026-02-10 | Cook Anne Marie | Sell | 1.53K | $12.82 | 19.68K |
| 2026-02-10 | Basta Steven L | Buy | 12.36K | — | — |
| 2026-02-10 | Basta Steven L | Sell | 6.28K | $12.82 | 80.47K |
| 2026-01-23 | Parikh Asit | Buy | 80.50K | — | — |
| 2026-01-23 | Parikh Asit | Sell | 80.50K | — | — |
| 2026-01-21 | Breedlove Robert Charles | Sell | 776 | $13.61 | 10.56K |
| 2026-01-13 | Parikh Asit | Buy | 8.75K | $10.30 | 90.12K |
| 2026-01-13 | Parikh Asit | Sell | 8.75K | $10.30 | 90.12K |
| 2026-01-02 | Basta Steven L | Buy | 251.03K | — | — |
| 2026-01-02 | Basta Steven L | Buy | 226.16K | $15.71 | 3.55M |
| 2026-01-02 | Cook Anne Marie | Buy | 75.34K | — | — |
| 2026-01-02 | Cook Anne Marie | Buy | 67.88K | $15.71 | 1.07M |
| 2026-01-02 | Narula Sanjeev | Buy | 82.72K | — | — |
| 2026-01-02 | Narula Sanjeev | Buy | 42.85K | $15.71 | 673.14K |
| 2025-12-19 | Parikh Asit | Buy | 8.75K | $10.30 | 90.12K |
| 2025-12-19 | Parikh Asit | Sell | 8.75K | $10.30 | 90.12K |
| 2025-12-18 | Breedlove Robert Charles | Sell | 230 | $16.28 | 3.74K |
| 2025-12-17 | Cook Anne Marie | Buy | 17.37K | — | — |
| 2025-12-17 | Cook Anne Marie | Sell | 7.70K | $15.36 | 118.32K |
| 2025-12-17 | Basta Steven L | Buy | 62.04K | — | — |
| 2025-12-17 | Basta Steven L | Sell | 31.50K | $15.36 | 483.87K |
| 2025-11-28 | Basta Steven L | Sell | 90.00K | — | — |
| 2025-11-28 | Basta Steven L | Buy | 90.00K | — | — |
| 2025-11-28 | Basta Steven L | Sell | 48.38K | $15.62 | 755.62K |
| 2025-11-03 | Breedlove Robert Charles | Sell | 524 | $13.51 | 7.08K |
| 2025-10-06 | Narula Sanjeev | Buy | 144.00K | — | — |
| 2025-10-06 | Narula Sanjeev | Buy | 200.00K | $11.61 | 2.32M |
| 2025-10-06 | Narula Sanjeev | Other | 0 | — | — |
| 2025-09-25 | Basta Steven L | Sell | 90.00K | — | — |
| 2025-09-25 | Basta Steven L | Buy | 90.00K | — | — |
| 2025-09-25 | Basta Steven L | Sell | 48.38K | $11.66 | 564.05K |
| 2025-09-05 | Breedlove Robert Charles | Sell | 461 | $12.09 | 5.57K |
| 2025-07-16 | Breedlove Robert Charles | Sell | 1.69K | $8.36 | 14.15K |
| 2025-06-23 | Cook Anne Marie | Buy | 210.00K | $9.47 | 1.99M |
| 2025-06-23 | Cook Anne Marie | Other | 0 | — | — |
| 2025-06-03 | KARBE FRANK | Buy | 10.50K | — | — |
| 2025-06-03 | KARBE FRANK | Buy | 17.50K | $4.95 | 86.62K |
| 2025-06-03 | COLA MICHAEL F | Buy | 10.50K | — | — |
| 2025-06-03 | COLA MICHAEL F | Buy | 17.50K | $4.95 | 86.62K |
| 2025-06-03 | Topper James N | Buy | 10.50K | — | — |
| 2025-06-03 | Topper James N | Buy | 17.50K | $4.95 | 86.62K |
| 2025-06-03 | FIELDS HEIDI | Buy | 10.50K | — | — |
| 2025-06-03 | FIELDS HEIDI | Buy | 17.50K | $4.95 | 86.62K |
| 2025-06-03 | Stenhouse Mark | Buy | 10.50K | — | — |
| 2025-06-03 | Stenhouse Mark | Buy | 17.50K | $4.95 | 86.62K |
| 2025-06-03 | Parikh Asit | Buy | 10.50K | — | — |
| 2025-06-03 | Parikh Asit | Buy | 17.50K | $4.95 | 86.62K |
| 2025-05-21 | Topper James N | Buy | 3.78K | $3.86 | 14.61K |
| 2025-05-19 | Breedlove Robert Charles | Buy | 33.00K | $4.39 | 144.87K |
| 2025-05-14 | Topper James N | Buy | 6.30K | $3.32 | 20.92K |
| 2025-05-13 | Topper James N | Buy | 1.12K | $3.16 | 3.54K |
| 2025-05-12 | Topper James N | Buy | 12.60K | $3.04 | 38.30K |
| 2025-05-09 | Topper James N | Buy | 2.23K | $3.62 | 8.05K |
| 2025-05-09 | Topper James N | Buy | 33.38K | $3.19 | 106.56K |
| 2025-05-07 | Parikh Asit | Buy | 5.00K | $2.40 | 11.98K |
| 2025-05-06 | Parikh Asit | Buy | 5.00K | $2.60 | 13.00K |
| 2025-05-01 | Breedlove Robert Charles | Other | 0 | — | — |
| 2025-05-01 | Breedlove Robert Charles | Other | 0 | — | — |
| 2025-05-01 | Breedlove Robert Charles | Other | 13.50K | $8.35 | 112.72K |
| 2025-05-01 | Breedlove Robert Charles | Other | 12.00K | $15.21 | 182.52K |
| 2025-05-01 | Breedlove Robert Charles | Other | 15.75K | $7.60 | 119.70K |
| 2025-05-01 | Breedlove Robert Charles | Other | 15.00K | $5.76 | 86.40K |
| 2025-04-16 | Schroeder Theodore R | Buy | 35.00K | $4.23 | 148.05K |
| 2025-04-16 | Schroeder Theodore R | Buy | 21.00K | — | — |
| 2025-04-16 | Schroeder Theodore R | Other | 0 | — | — |
| 2025-04-07 | Henderson Molly | Sell | 3.68K | $4.55 | 16.74K |
| 2025-04-03 | Basta Steven L | Buy | 1.08M | $5.01 | 5.44M |
| 2025-04-03 | Basta Steven L | Buy | 360.00K | — | — |
| 2025-04-01 | Basta Steven L | Other | 0 | — | — |
| 2025-03-13 | Parikh Asit | Buy | 10.00K | $4.42 | 44.20K |
| 2025-02-27 | Curran Terrie | Buy | 342.50K | $5.76 | 1.97M |
| 2025-02-27 | Henderson Molly | Buy | 72.00K | — | — |
| 2025-02-27 | Henderson Molly | Buy | 50.00K | $5.76 | 288.00K |
| 2025-02-27 | Nabulsi Azmi | Buy | 79.20K | — | — |
| 2025-02-27 | Nabulsi Azmi | Buy | 55.00K | $5.76 | 316.80K |
| 2025-01-21 | Henderson Molly | Sell | 6.58K | $6.59 | 43.37K |
| 2025-01-21 | Nabulsi Azmi | Sell | 7.89K | $6.59 | 51.96K |
| 2025-01-21 | Curran Terrie | Sell | 19.11K | $6.59 | 125.88K |
| 2024-12-19 | Nabulsi Azmi | Sell | 1.12K | $8.00 | 8.94K |
Latest filed quarter: Q2 2026.
Institutions holding: 173, holders -6 vs prior quarter. Ownership 86.56%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 12.47M | 0 | 0.00% | 135.26M |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 7.46M | 0 | 0.00% | 80.99M |
| BLACKROCK, INC. | 4.53M | 463.13K | +11.40% | 49.10M |
| INVESCO LTD. | 4.03M | -292.33K | -6.76% | 43.72M |
| CARLYLE GROUP INC. | 3.50M | 0 | 0.00% | 37.94M |
| MILLENNIUM MANAGEMENT LLC | 3.38M | -647.08K | -16.08% | 36.63M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.66M | 73.31K | +2.84% | 28.83M |
| GW&K INVESTMENT MANAGEMENT, LLC | 2.17M | 745.73K | +52.48% | 23.51M |
| FRANKLIN TEMPLETON INC | 1.97M | 976.32K | +98.17% | 21.38M |
| NEA MANAGEMENT COMPANY, LLC | 1.96M | 0 | 0.00% | 21.27M |
| 683 CAPITAL MANAGEMENT, LLC | 1.85M | 0 | 0.00% | 20.07M |
| GOLDMAN SACHS GROUP INC | 1.78M | 1.15M | +183.94% | 19.29M |
| STATE STREET CORP | 1.59M | 199.43K | +14.38% | 17.21M |
| CATALYS PACIFIC, LLC | 1.49M | 0 | 0.00% | 16.21M |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.46M | 257.37K | +21.35% | 15.87M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.32M | -12.36K | -0.93% | 14.28M |
| WASATCH ADVISORS LP | 1.31M | -33.67K | -2.51% | 14.18M |
| ENSIGN PEAK ADVISORS, INC | 1.05M | -575.89K | -35.38% | 11.41M |
| PROPEL BIO MANAGEMENT, LLC | 1.05M | 209.09K | +24.85% | 11.40M |
| POINT72 ASSET MANAGEMENT, L.P. | 1.02M | 1.02M | New | 11.09M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 796.63K | 130.60K | +19.61% | 8.64M |
| SUMMITTX CAPITAL, L.P. | 789.55K | -206.34K | -20.72% | 8.57M |
| HSBC HOLDINGS PLC | 709.70K | 709.70K | New | 7.70M |
| MARSHALL WACE, LLP | 666.09K | -194.60K | -22.61% | 7.23M |
| ECOR1 CAPITAL, LLC | 625.00K | 0 | 0.00% | 6.78M |
Insights · Dividends · Forecast · Financials · Learn
$508.06M
Market Cap
-4.48
P/E
8.76
Forward P/E
68
Score